A Randomized, Open-label, Single-dose, Two-period, Two-treatment Crossover Study Evaluating the Effects of Food on the Pharmacokinetics of SY-5007 Tablets in Chinese Healthy Subjects
Latest Information Update: 26 Mar 2024
At a glance
- Drugs SY-5007 (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Shouyao Holdings
- 26 Mar 2024 New trial record